Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neladenoson bialanate Phase 2 study in cardiovascular disease (Japan)
jRCT2080223546Phase 2Completed
- Start
- May 2017
- Modality
- Small Molecules
01
Overview
Phase 2 trial of neladenoson bialanate in cardiac morbidity. Started May 2017; status: completed.
02
Drugs
neladenoson bialanate
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on jRCT2080223546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223546.